Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Haemophilus Infections | 2 | 2018 | 69 | 1.36 | Why? |
| Hospital Bed Capacity | 2 | 2020 | 1300 | 0.93 | Why? |
| Emergency Shelter | 1 | 2020 | 202 | 0.75 | Why? |
| Haemophilus influenzae type b | 1 | 2017 | 30 | 0.71 | Why? |
| Cost-Benefit Analysis | 2 | 2018 | 2259 | 0.70 | Why? |
| Haemophilus Vaccines | 1 | 2017 | 76 | 0.68 | Why? |
| Haemophilus influenzae | 1 | 2018 | 196 | 0.67 | Why? |
| Bacterial Vaccines | 1 | 2018 | 139 | 0.65 | Why? |
| Bed Occupancy | 1 | 2020 | 476 | 0.63 | Why? |
| Ontario | 5 | 2021 | 1966 | 0.61 | Why? |
| Immunization, Secondary | 3 | 2021 | 1649 | 0.61 | Why? |
| Vaccination | 9 | 2021 | 19050 | 0.59 | Why? |
| Immunization Schedule | 2 | 2021 | 1305 | 0.54 | Why? |
| Zika Virus Infection | 2 | 2018 | 1920 | 0.53 | Why? |
| Disease Outbreaks | 7 | 2021 | 27595 | 0.53 | Why? |
| Asymptomatic Infections | 3 | 2021 | 7218 | 0.51 | Why? |
| Basic Reproduction Number | 3 | 2021 | 2676 | 0.48 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.45 | Why? |
| Long-Term Care | 2 | 2021 | 2047 | 0.45 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.45 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.41 | Why? |
| Patient Transfer | 1 | 2017 | 898 | 0.40 | Why? |
| Clostridium Infections | 1 | 2017 | 595 | 0.39 | Why? |
| Models, Theoretical | 5 | 2021 | 6659 | 0.34 | Why? |
| Disease Transmission, Infectious | 2 | 2021 | 9044 | 0.30 | Why? |
| Monte Carlo Method | 2 | 2018 | 577 | 0.28 | Why? |
| Patient Acceptance of Health Care | 2 | 2021 | 5002 | 0.28 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.27 | Why? |
| Schools | 1 | 2020 | 4187 | 0.27 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.27 | Why? |
| Contact Tracing | 3 | 2021 | 8448 | 0.26 | Why? |
| Incidence | 7 | 2020 | 25622 | 0.25 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.25 | Why? |
| United States | 8 | 2021 | 46150 | 0.23 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.23 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.20 | Why? |
| Cross Infection | 2 | 2017 | 8675 | 0.18 | Why? |
| Masks | 1 | 2020 | 8528 | 0.17 | Why? |
| Radio Waves | 1 | 2017 | 27 | 0.17 | Why? |
| Systems Analysis | 1 | 2021 | 366 | 0.17 | Why? |
| Probability | 2 | 2021 | 923 | 0.17 | Why? |
| Canada | 2 | 2020 | 6018 | 0.16 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.16 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.15 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.15 | Why? |
| Humans | 26 | 2021 | 930598 | 0.15 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.15 | Why? |
| Influenza, Human | 2 | 2018 | 10779 | 0.15 | Why? |
| Stochastic Processes | 1 | 2017 | 369 | 0.15 | Why? |
| Vaccines, Conjugate | 1 | 2017 | 328 | 0.14 | Why? |
| Patient Isolation | 2 | 2020 | 3182 | 0.14 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.14 | Why? |
| Immunization Programs | 2 | 2018 | 2006 | 0.14 | Why? |
| Computer Simulation | 2 | 2021 | 4982 | 0.14 | Why? |
| Communicable Disease Control | 3 | 2021 | 29620 | 0.14 | Why? |
| Mosquito Vectors | 1 | 2017 | 351 | 0.14 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.13 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.13 | Why? |
| Child | 5 | 2021 | 70012 | 0.13 | Why? |
| Aedes | 1 | 2017 | 380 | 0.13 | Why? |
| Colombia | 1 | 2018 | 1241 | 0.13 | Why? |
| Population Dynamics | 1 | 2017 | 378 | 0.13 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.13 | Why? |
| Models, Statistical | 2 | 2021 | 5312 | 0.12 | Why? |
| Infant | 3 | 2020 | 30274 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Child, Preschool | 3 | 2020 | 36283 | 0.10 | Why? |
| Health Care Costs | 1 | 2018 | 1007 | 0.10 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.09 | Why? |
| Epidemics | 2 | 2020 | 6407 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.09 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.08 | Why? |
| Aged | 5 | 2021 | 215776 | 0.08 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.07 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Public Health | 3 | 2020 | 16359 | 0.07 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.07 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.07 | Why? |
| Travel | 1 | 2020 | 7220 | 0.05 | Why? |
| Developing Countries | 1 | 2017 | 4283 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Male | 4 | 2021 | 367725 | 0.05 | Why? |
| Female | 4 | 2021 | 380317 | 0.04 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.04 | Why? |
| Adult | 3 | 2021 | 244371 | 0.04 | Why? |
| Likelihood Functions | 1 | 2020 | 719 | 0.04 | Why? |
| Middle Aged | 3 | 2020 | 270681 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.03 | Why? |
| Health Planning | 1 | 2021 | 607 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2021 | 23402 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Animals | 1 | 2017 | 78931 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 8811 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |